Semaglutide​ (trade name Wegovy), which became a popular "weight loss miracle drug" for helping the world's richest man Elon Musk successfully lose weight, has once again appeared in the New England Journal of Medicine (NEJM).

40% of the world's population is overweight

Winter Solstice is a poetic solar term that carries the sediment of time, the warmth of humanity, and the sprouting of hope.

Semaglutide is a drug belonging to the GLP-1 (glycosaminopeptide-1) receptor agonist category used to treat obesity.

Semaglutide, making your weight loss journey safer, easier, and non rebound!

Lilly Launch of Retatrutide Phase 3 Clinical Trial

Semaglutide is a new generation of GLP-1 (Glucagon-like peptide-1) analog developed by Novo Nordisk Nordisk of Denmark. Its Molecular formula is C187H291N45O59, and its molecular weight is 4113.58. Semaglutide is based on the basic structure of Liraglutide and optimized on the basis of Liraglutide structure: it is obtained by changing alanine and lysine at positions 8 and 26 of Liraglutide to 2-amino Isobutyric acid and arginine, adding spacer (PEG chain) and acylating with stearic acid. This structure not only enhances the efficacy of Semaglutide, but also prolongs its half-life.

Just take medication once a week, Lose nearly 30 pounds!

How Musk Loses 18 pounds a Month

In March, the spring is full of air, the breeze is blowing, and the fragrance of flowers is overflowing. In this season of recovery of all things, we take a brisk step to go hiking in the wild. At 9 o'clock in the morning, we came to Xianyuling Park and felt the breath of spring, the warm sunshine, the fresh air, the whirling willows, and blooming flowers. Colleagues sing and jump to find the breath of spring and feel the changes of spring. We swim in the arms of nature and revel in the beauty of Xianyuling Park.